Oncolytic reovirus shows potentially anticancer effect against CT26 cell lines

Abstract

Background: Reovirus type 3 Dearing (T3D) is a segmented double-stranded RNA that selectively replicates and triggers anticancer responses in the KRAS mutant cancer cells. Here, we examine the anticancer activity of ReoT3D against murine colon carcinoma cell line (CT26) with deferent in vitro experiments. Results: Our results showed that ReoT3D significantly induced oncolysis in the CT26 cells by induction of apoptosis, and cell cycle arrest in the G0/G1 and G2/M checkpoints and reduction of cell migration and colony forming ability. Conclusion: Present study confirmed that ReoT3D has strong anticancer impacts on CT26 cells which can be considered as a new approach against KRAS mutant cancer cell lines in laboratory investigation.